Citation Impact 2023
Journal Impact Factor: 5.7
5-year Journal Impact Factor: 6.0
Source Normalized Impact per Paper (SNIP): 1.749
SCImago Journal Rank (SJR): 2.061
Speed 2023
Submission to first editorial decision (median days): 7
Submission to acceptance (median days): 91
Usage 2023
Downloads: 1,737,465
Altmetric mentions: 6,851
Severe infections requiring intensive care unit admission in patients receiving ibrutinib for hematological malignancies: a groupe de recherche respiratoire en réanimation onco-hématologique (GRRR-OH) study
In the last decade, Ibrutinib has become the standard of care in the treatment of several lymphoproliferative diseases such as chronic lymphocytic leukemia (CLL) and several non-Hodgkin lymphoma. Beyond Bruton...